help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 13, 2007
Molecular Endocrinology, doi:10.1210/me.2006-0270
A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
21/5/1163    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magni, P.
Right arrow Articles by Maggi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magni, P.
Right arrow Articles by Maggi, R.

Submitted on June 30, 2006
Accepted on February 6, 2007

Leukemia Inhibitory Factor Induces the Chemomigration of Immortalized Gonadotropin-Releasing Hormone Neurons through the Independent Activation of the Jak/STAT3, MAPK/ERK1/2 and PI3-K/Akt Signalling Pathways

Paolo Magni*, Elena Dozio, Massimiliano Ruscica, Hajime Watanobe, Anna Cariboni, Roberta Zaninetti, Marcella Motta, and Roberto Maggi

Department of Endocrinology, Centre of Excellence on Neurodegenerative Diseases, University of Milan, Milan, Italy; Division of Internal Medicine, Center for Clinical Research, International University of Health and Welfare, Otawara, Japan

* To whom correspondence should be addressed. E-mail: paolo.magni{at}unimi.it.

Leukemia inhibitory factor (LIF) is a pleiotropic cytokine of the IL-6 superfamily. LIF acts through a cell-surface receptor complex formed by two subunits, the specific LIF receptor {beta} (LIFR{beta}) and the glycoprotein 130 (gp130). Little is known about LIF involvement in modulating the neuroendocrine circuitry governing the reproductive function and, specifically, the development of GnRH-secreting neurons. In the present study, we evaluated the effect of LIF on the in vitro migration of GN11 cells, a model of immature and migratory GnRH neurons, and the signalling pathways involved in this process. GN11 cells expressed both LIFR{beta} and gp130 subunits. Exposure of GN11 cells to 100 ng/mL LIF resulted in activation of the Janus kinases (Jaks)/ signal transducer and activator of transcription 3 (STAT3), MAPK/ERK1/2 and phosphatidylinositol 3-kinase (PI3-K)/protein kinase B (PKB/Akt) pathways. The selective inhibition of Jaks, MEK (mitogen-activated protein kinase kinase) and PI3-K indicated that these signalling pathways were activated independently by LIF and that Jak2 is not the main kinase involved in LIF signalling. Exposure of GN11 cells to LIF for 3 h induced a concentration-dependent chemotactic response, with a plateau at 100 ng/mL LIF. LIF was also found to induce chemokinesis of GN11 cells. Furthermore, LIF-promoted GN11 migration was the result of the partial and independent contribution of all the three signalling pathways activated by LIF. The present data, together with the observation that LIF and LIFR{beta} are expressed prenatally in the mouse nasal compartment, would suggest that LIF may participate in the migration of GnRH neurons.


Key words: LIF • GnRH neuron migration • STAT3 • ERK1/2 • Akt







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society